Everence Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Everence Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,850	Closed	-$299K	–	864
2025 Q4	$299K	Hold	4,850	–	–	0.02%	588
2025 Q3	$303K	Hold	4,850	–	–	0.02%	607
2025 Q2	$387K	Hold	4,850	–	–	0.02%	470
2025 Q1	$417K	Sell	4,850 -530	-10%	-$43.5K	0.03%	419
2024 Q4	$420K	Sell	5,380 -1,250	-19%	-$97K	0.03%	428
2024 Q3	$478K	Hold	6,630	–	–	0.03%	437
2024 Q2	$476K	Hold	6,630	–	–	0.03%	407
2024 Q1	$481K	Hold	6,630	–	–	0.03%	415
2023 Q4	$406K	Hold	6,630	–	–	0.03%	460
2023 Q3	$379K	Hold	6,630	–	–	0.03%	470
2023 Q2	$379K	Hold	6,630	–	–	0.03%	442
2023 Q1	$415K	Hold	6,630	–	–	0.03%	418
2022 Q4	$415K	Hold	6,630	–	–	0.04%	434
2022 Q3	$330K	Hold	6,630	–	–	0.03%	481
2022 Q2	$390K	Sell	6,630 -2,010	-23%	-$111K	0.03%	434
2022 Q1	$457K	Buy	8,640 +2,010	+30%	+$116K	0.04%	431
2021 Q4	$402K	Hold	6,630	–	–	0.03%	495
2021 Q3	$372K	Buy	+6,630	New	+$364K	0.03%	497

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Everence Capital Management's PBH Position: Q1 2026 in Review

Everence Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 4,850 shares — an estimated $299K sold.

Everence Capital Management first reported a position in PBH in Q3 2021 and held it in 18 quarters. The position peaked at $481K in Q1 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

Everence Capital Management reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 4,850 Prestige Consumer Healthcare shares in Q1 2026, an estimated $299K.
Everence Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 18 quarters.
Everence Capital Management's Prestige Consumer Healthcare position peaked at $481K in Q1 2024.
355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.